CAS 114568-26-2

Patamostat

CAS: 114568-26-2

Patamostat (E-3123) inhibits trypsin, plasmin, and thrombin; may reduce acute pancreatitis progression. IC50: trypsin 39 nM, plasmin 950 nM, thrombin 1.9 μM.

Formula: C₂₀H₂₀N₄O₄S

Color and Shape: Solid

Molecular weight: 412.46

Ref: TM-T9670

Patamostat

CAS: 114568-26-2

Patamostat is a potent kinase inhibitor that has been shown to inhibit the activity of various kinases in vitro and in vivo. It is excreted primarily through urine and has been shown to have a high degree of selectivity for specific kinases, making it an ideal candidate for cancer therapy. Patamostat induces apoptosis in cancer cells and has been used as an analog for anticancer research. This drug has demonstrated efficacy against tumors in Chinese hamsters, and its inhibitors have shown promise in blocking the growth of human cancer cells. Patamostat may also have potential therapeutic applications beyond cancer treatment due to its ability to inhibit protein kinases.

Formula: C₂₀H₂₀N₄O₄S

Purity: Min. 95%

Molecular weight: 412.5 g/mol

Ref: 3D-PEA56826